Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,918.50
Bid: 1,925.50
Ask: 1,927.00
Change: 0.00 (0.00%)
Spread: 1.50 (0.078%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,918.50
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

25 Aug 2016 09:07

Britain's FTSE retreats as pharma stocks fall

(ADVISORY- Follow European and UK stock markets in real time on the Reuters Live Markets blog on Eikon, see cpurl://apps.cp./cms/?pageId=livemarkets) * FTSE 100 down 0.8 pct * Pharma stocks down after Clinton's EpiPen comments * Glencore leads miners lower * CRH rises afte

Read more
25 Aug 2016 08:58

BUZZ-European pharma: top fallers on Stoxx 600 amid pricing pressure concern

** Hikma Pharmaceuticals, Shire, Qiagen , BB Biotech fall 3-5 pct ** Track weakness overnight in US healthcare, dragged down by >5% drop in Mylan as political pressure mounted on company after price increases for its EpiPen allergy treatment ** Democratic presidential candidate Hillar

Read more
24 Aug 2016 13:53

Broker tips: Hikma, Drax, TT Electronics

(ShareCast News) - Hikma Pharmaceuticals' shares have been maintain as 'hold' by Numis, with a target price of 2660p, following the company's surprise profit warning earlier in August and its interim numbers out on Wednesday. In the six months to end-June, Hikma's core revenue rose to $882m, from $7

Read more
24 Aug 2016 13:25

Hikma Pharmaceuticals maintained as 'Hold' by Numis with 2660p price target

(ShareCast News) - Hikma Pharmaceuticals' shares have been maintain as 'Hold' by Numis, with a target price of 2660p, following the company's surprise profit warning earlier in August and its interim numbers out on Wednesday. In the six months to end-June, Hikma's core revenue rose to $882m, from $7

Read more
24 Aug 2016 09:10

CORRECT: Hikma Keeps 2016 Guidance, Interim Dividend As Profit Down

Read more
24 Aug 2016 07:48

Hikma H1 operating profit drops but FY revenue guidance reiterated

(ShareCast News) - Hikma Pharmaceuticals reported a jump in first-half revenues but a drop in operating profit, as it reiterated its full-year revenue guidance. In the six months to the end of June, core revenue rose to $882m from $709m, but operating profit slipped to $176m from $204m due to a lowe

Read more
23 Aug 2016 13:58

FTSE 100 movers: Housebuilders lead equities higher

(ShareCast News) - The FTSE 100 rose 0.66% to 6,873.69 points in afternoon trade on Tuesday, with housebuilders topping the London index. Persimmon led housebuilders higher after reporting a better-than-expected jump in first half profits. Pre-tax profit rose 29% to £352.3m in the six months to 30 J

Read more
23 Aug 2016 12:29

Wednesday preview: Hikma Pharmaceuticals reports interims in wake of profit warning

(ShareCast News) - Hikma Pharmaceuticals reports its interim results on Wednesday just weeks after surprising the market with a profit warning. In a first half trading update on 4 August, the drug maker said it expected core operating profit of its generics arm to be between $30m and $40m, compared

Read more
17 Aug 2016 15:05

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
10 Aug 2016 15:59

LONDON MARKET CLOSE: Stocks Extend Rally Despite Brent Nearing USD44

Read more
10 Aug 2016 11:05

LONDON MARKET MIDDAY: Stocks Consolidate Gains After Four-Day Rally

Read more
10 Aug 2016 08:35

BROKER RATINGS SUMMARY: Panmure Raises RSA Insurance To Buy From Hold

Read more
5 Aug 2016 09:29

WINNERS & LOSERS SUMMARY: Upbeat Bellway Lifts Housebuilding Stocks

Read more
5 Aug 2016 08:31

BROKER RATINGS SUMMARY: S&P And Shore Upgrade Aviva After Strong Half

Read more
5 Aug 2016 07:33

LONDON MARKET OPEN: RBS Misses Gains After Swinging To Operating Loss

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.